ArticleWorld journal of gastroenterology2026
Clinical implications of a dynamic nomogram for predicting sepsis in acute liver failure.
Article in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This letter comments on a web-enabled, dynamic nomogram developed for early sepsis-risk estimation in adults with acute liver failure (ALF) admitted to the intensive care unit. The study successfully established and validated the sepsis in ALF model using five routinely available variables: Age, total bilirubin, lactate dehydrogenase, albumin, and mechanical ventilation. Across cohorts, the model demonstrated strong discrimination and outperformed traditional scores. We commend the inclusion of both Western and Chinese intensive care unit cohorts, which enhances the cross-population generalizability of the findings. This letter highlights the strengths of the model, including its web-based dynamic calculator and effective risk stratification, while also acknowledging limitations such as reliance on baseline admission data, restriction to intensive care unit populations, and the absence of infection-related biomarkers. We encourage further prospective, multicenter investigations to refine the sepsis in ALF model and expand its clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.